SG Americas Securities, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 165 filers reported holding CARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$114
-19.1%
67,954
+36.1%
0.00%0.0%
Q2 2023$141
-61.8%
49,932
-33.5%
0.00%
-75.0%
Q1 2023$369
-28.5%
75,067
+56.2%
0.00%
-33.3%
Q4 2022$516
-99.9%
48,067
+3.7%
0.01%
+20.0%
Q3 2022$434,000
-26.8%
46,366
-28.6%
0.01%
-16.7%
Q2 2022$593,000
-35.2%
64,938
-13.8%
0.01%
-14.3%
Q1 2022$915,000
-17.7%
75,333
-17.5%
0.01%
+16.7%
Q4 2021$1,112,000
-22.4%
91,305
-1.6%
0.01%
-14.3%
Q3 2021$1,433,000
+250.4%
92,749
+223.6%
0.01%
+250.0%
Q2 2021$409,000
-65.4%
28,666
-47.3%
0.00%
-66.7%
Q1 2021$1,182,000
-48.2%
54,433
-63.9%
0.01%
-50.0%
Q4 2020$2,283,000
+34.8%
150,901
+13.4%
0.01%
+9.1%
Q3 2020$1,694,000
-14.9%
133,094
+14.3%
0.01%
-35.3%
Q2 2020$1,991,000
+418.5%
116,430
+300.7%
0.02%
+325.0%
Q1 2020$384,000
+29.3%
29,055
+57.8%
0.00%
+33.3%
Q4 2019$297,000
+17.4%
18,408
+33.0%
0.00%
+50.0%
Q3 2019$253,000
-59.1%
13,839
-51.9%
0.00%
-50.0%
Q2 2019$618,000
+60.5%
28,760
+46.7%
0.00%0.0%
Q1 2019$385,000
-72.3%
19,599
-81.6%
0.00%
-66.7%
Q4 2018$1,388,000
+300.0%
106,733
+321.0%
0.01%
+300.0%
Q3 2017$347,00025,3530.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders